• "Familial Multiple Coagulation Factor Deficiencies of FXI and FXII in an Asymptomatic Saudi Woman"
• A Case Report of Severe Factor XI Deficiency during Cardiac Surgery: Less Can Be More
• A novel F11 mutation in a Korean pediatric patient with recurrent epistaxis
• A novel factor XI gene mutation associated with mild factor XI deficiency in a symptomatic patient
• A successful case of laparoscopic colorectal cancer resection in an elderly patient with factor XI deficiency
• A surgical case of cerebral hemorrhage in a patient with factor XI deficiency
• Acquired factor XI deficiency and therapeutic plasma exchange
• ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant
• An elderly case of congenital prekallikrein deficiency
• An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency
• An uncommon cause of hematemesis in children: factor XI deficiency
• Analysis of a pedigree affected with hereditary coagulation factor XI deficiency due to compound heterozygous variants of F11 gene
• Anticoagulant therapy in patients with congenital FXI deficiency
• Appropriate laboratory investigation in women with menorrhagia
• Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review
• Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency
• Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre
• CaMKIV mediates spine growth deficiency of hippocampal neurons by regulation of EGR3/BDNF signal axis in congenital hypothyroidism
• CD36-fibrin interaction propagates FXI-dependent thrombin generation of human platelets
• CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features
• Cdh1 regulates craniofacial development via APC-dependent ubiquitination and activation of Goosecoid
• Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week
• Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China
• Coagulation abnormalities and vascular complications are common in PGM1-CDG
• Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation
• Coagulation factor XI as a novel target for antithrombotic treatment
• Coagulation factor XI gene analysis in three factor XI deficient Austrian patients
• Combined Congenital Hypodysfibrinogemia and Factor XI Deficiency in a Chinese Family
• Combined high molecular weight Kininogen and factor XI deficiency
• Comprehensive care for hemophilia and other inherited bleeding disorders
• Congenital deficiencies of coagulation factors and acquired inhibitors leading to bleeding disorders
• Congenital factor deficiency: a retrospective analysis of 80 cases
• Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation
• Congenital factor XI deficiency and risk of heart failure in humans
• Congenital factor XI deficiency caused by a novel F11 missense variant: a case report
• Congenital factor XI deficiency with multiple tooth extractions (Case report)
• Congenital factor XI deficiency, complete genotype and phenotype of two Iranian families
• Congenital factor Ⅺ deficiency: a retrospective analysis of 80 cases
• Congenital factor XI deficiency: an update
• Correction of factor XI deficiency by liver transplantation
• Deep venous thrombosis treated by rivaroxaban in a young patient with type Ia carbohydrate-deficient glycoprotein (CDG) syndrome
• Diagnosis and management of factor XI alloinhibitors in patients with congenital factor XI deficiency-A large single-centre experience
• Diagnosis of Factor XI deficiency following congenital cataract extraction
• Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings
• Factor XI and factor XII as targets for new anticoagulants
• Factor XI deficiency: actuality and review of the literature
• Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship
• Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous vein
• Factor XIa inhibition as a therapeutic strategy for atherothrombosis
• Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature
• Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma
• Genetic analysis of a pedigree with combined factor XII and factor XI deficiency
• Global coagulation tests to assess the value of the presurgical treatment in a patient with congenital factor XI deficiency and inhibitor
• Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study
• Hemarthrosis revealing congenital factor XI deficiency
• Hemostatic defects in congenital disorders of glycosylation
• Identification of a novel F11 missense mutation (Ile463Ser) in a family with congenital factor XI deficiency
• Impact of genetic structural variants in factor XI deficiency: identification, accurate characterization, and inferred mechanism by long-read sequencing
• Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia
• Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
• Ischemic Strokes in Congenital Bleeding Disorders: Comparison with Myocardial Infarction and other Acute Coronary Syndromes
• Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?
• Low endoscopy bleeding risk in patients with congenital bleeding disorders
• Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report
• Management of mild congenital deficiency of Factor XI with a Factor XI inhibitor in pregnancy: A clinical case
• Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia
• Molecular characterization of FXI deficiency
• Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature
• Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases
• New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond
• Non-syndromic familial congenital dental deficiency: two cases report
• Novel mutations p.Lys327X and p.Leu424CysfsX8 underlying congenital factor deficiency
• Novel mutations p.Lys327X and p.Leu424CysfsX8 underlying congenital factor Ⅺ deficiency
• Occurrence of thrombosis in rare bleeding disorders
• Opening Pandora's box: abnormal genetic carrier screening and need for lifetime follow-up
• Percutaneous coronary intervention in a patient with congenital factor XI deficiency and acquired inhibitor
• Performance and Interpretation of Clot Waveform Analysis
• Perioperative management and neuraxial analgesia in women with factor XI deficiency (<60 IU/dL): a French multicenter observational study of 314 pregnancies
• Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China
• Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX
• Practical aspects of extended half-life products for the treatment of haemophilia
• Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors
• Progressive multifocal leukoencephalopathy in a patient with novel mutation in the RAC2 gene: a case report
• Prothrombin Complex Concentrate
• Prothrombin Complex Concentrate
• Rare bleeding disorders in children: identification and primary care management
• Real-World Use of Albutrepenonacog Alfa, A Recombinant Coagulation Factor IX Albumin Fusion Protein, for Personalized Prophylaxis in Japanese Individuals With Hemophilia B: A Case Series
• Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery
• Recurrent episodes of severe bleeding caused by congenital factor XIII deficiency in a dog
• Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation
• Successful treatment of a patient with colon cancer with congenital coagulation factor XI deficiency
• Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency
• Surgical interventions in childhood rare factor deficiencies: a single-center experience from Turkey
• The intrinsic pathway of coagulation: a target for treating thromboembolic disease?
• The use of desmopressin in congenital factor XI deficiency: a systematic review
• Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency
• Thrombosis in rare bleeding disorders
• Transfusion of blood and components in critically ill children
• Update on the physiology and pathology of factor IX activation by factor XIa
• Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports